Endra Life Sciences Inc (NDRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 794 | 1,809 | 2,065 | 3,230 | 4,745 |
| TOTAL | $1,049 | $1,853 | $2,180 | $3,434 | $4,962 |
| Non-Current Assets | |||||
| PPE Net | 53 | 63 | 73 | 69 | 80 |
| Other Non-Current Assets | 863 | 891 | 918 | 949 | 3,337 |
| TOTAL | $915 | $955 | $990 | $1,019 | $3,417 |
| Total Assets | $1,964 | $2,808 | $3,171 | $4,452 | $8,379 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 672 | 448 | 440 | 508 | 627 |
| TOTAL | $800 | $577 | $566 | $605 | $814 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 992 | 758 | 852 | 1,287 | 960 |
| TOTAL | $992 | $758 | $852 | $1,287 | $960 |
| Total Liabilities | $1,793 | $1,335 | $1,418 | $1,892 | $1,774 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,166 | 753 | 738 | 562 | 537 |
| Retained earnings | -107,296 | -105,700 | -104,474 | -103,438 | -99,289 |
| TOTAL | $171 | $1,473 | $1,753 | $2,560 | $6,605 |
| Total Liabilities And Equity | $1,964 | $2,808 | $3,171 | $4,452 | $8,379 |